Developments reported around 8 July 2026 by the Israel Patent Office and in related case law further clarify the boundary for software- and AI-related patent claims. Following the position confirmed in the 2026 DABUS decision, an inventor named in an Israeli patent application must still be a natural person. On patent eligibility, merely implementing business logic, administrative processes or abstract rules with AI is unlikely to be enough. Applicants need to link the algorithm to a specific technical problem, system architecture and measurable result, such as stronger data security, lower...
Israel has recently updated the application of its Extension of Periods and Postponement of Deadlines Law in response to the regional situation, giving temporary breathing room for selected regulatory approvals and certain administrative time limits. For IP owners and representatives, the relief may help where filings, responses or supporting documents are affected by disrupted operations. It should not be treated as a blanket extension, however. The competent authority, including the Israel Patent Office in relevant matters, may still shorten or remove the relief depending on the facts of...
Israel’s 2026 patent fee schedule is now being applied in practice, and the change is broader than a routine tariff update. The filing fee, excess-claim fee and later renewal tranches now sit in clearer view at the start of the prosecution timeline, forcing applicants to think earlier about claim count, drafting scope and whether Israel is still a priority market at national-phase entry.The more important message in July 2026 is procedural. Israel continues to apply a hard 30-month deadline for PCT national-phase entry, and that applies under both Article 22 and Article 39 routes. Recent...
This article updates our report of 5 July, “Israel Reaffirms a Hard 30-Month PCT Deadline as Fees Shift”.
The latest WIPO PCT Applicant’s Guide continues to list Israel’s national phase deadline at 30 months from the priority date under both PCT Articles 22 and 39. Unlike jurisdictions that routinely allow entry at 31 months, Israel does not offer that extra month as a standard filing window. Where the 30-month deadline is missed, a request for restoration may be available under PCT Rule 49.6, but the Israel Patent Office applies a “due care” standard and the circumstances must be properly...
On 17 September WIPO issued Information Notice No. 39/2026: at the request of the Israel trade mark office, the Madrid individual fee for designating Israel changes from 17 October 2026. For an international application or a subsequent designation, the fee for one class rises from CHF 471 to CHF 503 and the fee for each additional class from CHF 354 to CHF 378; for renewal, the fee for one class rises from CHF 840 to CHF 896 and for each additional class from CHF 709 to CHF 757. The new amounts apply to international applications received by the Office of origin on or after 17 October,...
